← Eichor
Condition: Oral Anticoagulation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Oral Anticoagulation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Early Surgical Fixation of Low-Velocity Hip Fractures in Patients With Direct Oral Anticoagulation
Phase N/A · 1 location(s) · Medical University of Vienna · NCT05070169A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
Phase 3 · 64 location(s) · Takeda · NCT05156983LAAO Versus NOAC in Patients with AF and PCI
NA · 1 location(s) · Xijing Hospital · NCT05353140The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial
Phase 3 · 19 location(s) · Population Health Research Institute · NCT04284839Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
Phase 4 · 14 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06571149Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
Phase N/A · 10 location(s) · McMaster University · NCT06844227Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)
NA · 1 location(s) · Clinique Pasteur · NCT03297281Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
NA · 1 location(s) · Guangdong Provincial People's Hospital · NCT07441382Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
NA · 33 location(s) · Jena University Hospital · NCT04298723Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replac
Phase 4 · 16 location(s) · Joon Bum Kim · NCT04258488Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06692504Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06954610Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Phase 3 · 34 location(s) · Region Stockholm · NCT05679024Responding to AF: Pill-in-Pocket Anticoagulation Guided by Automated Monitoring and Alerts
NA · 1 location(s) · Oxford University Hospitals NHS Trust · NCT06922695Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation
Phase N/A · 12 location(s) · Fundación EPIC · NCT06863155Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (
Phase N/A · 1 location(s) · Nedim Tojaga · NCT06949319Atrial Fibrillation Screening Post Ischemic Cerebrovascular Events
NA · 1 location(s) · Karolinska Institutet · NCT05134454Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
Phase N/A · 33 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06556446STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for O
Phase 4 · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT06901466Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal Dise
Phase 4 · 6 location(s) · Hospital Sirio-Libanes · NCT06402851Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation
NA · 15 location(s) · University of Aarhus · NCT03642509Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated
NA · 7 location(s) · Javelin Medical · NCT05723926Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation
NA · 30 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05976685Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants
Phase N/A · 47 location(s) · University of L'Aquila · NCT06823466Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is
Phase 3 · 18 location(s) · Regeneron Pharmaceuticals · NCT07430956Effect of Apiban Therapy on AVF Maturation in ESRD Patients
NA · 1 location(s) · Combined military hospital lahore · NCT07559942Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With
Phase 4 · 105 location(s) · Population Health Research Institute · NCT03968393Oral Anticoagulation Versus Left Atrial Appendage Occlusion Added to Direct Oral Anticoagulation in Patients with Stroke
NA · 1 location(s) · Hospital Clinic of Barcelona · NCT06869811Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · 789 location(s) · Anthos Therapeutics, Inc. · NCT05712200Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
NA · 37 location(s) · Capital Medical University · NCT07139314
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.